The clinical significance and optimization strategies of HBeAg seroclearance in chronic hepatitis B treatment. [PDF]
Zhang Y +7 more
europepmc +1 more source
High-resolution mapping of chromatin conformation in HBeAg-treated macrophage provides insights into pathogenesis of HBV-related liver diseases. [PDF]
Liu T +8 more
europepmc +1 more source
Traditional Chinese Medicine in Chronic Hepatitis B: Integrating Antiviral Effects and Immune Modulation in the Context of T Cell Exhaustion. [PDF]
Zhao X +6 more
europepmc +1 more source
Immunochemical characteristics of hepatitis Be antigen subspecificties, HBeAg/1 and HBeAg/2
openaire +1 more source
Efficacy and safety of tenofovir alafenamide in HBeAg-positive and negative chronic hepatitis B patients aged over 30 years with normal ALT and detectable HBV DNA: a 96-week retrospective two-center study. [PDF]
Li Y, Sun J, Liu X, Yu H, Liu Y, Sun N.
europepmc +1 more source
Molecular Basis and Clinical Significance of the High-risk Phenotype of Hepatitis B Virus Genotype C. [PDF]
Huang C, Liu Z, Zhang J, Shen T, Sang L.
europepmc +1 more source
Challenges in the Management of Hepatitis B Among Children and Adolescents: A 10-Year Single-Center Experience. [PDF]
Dobrzeniecka A +7 more
europepmc +1 more source
Hepatitis B core-related antigen as a multifaceted biomarker in chronic hepatitis B: implications for immune activity and hepatocellular carcinoma prediction. [PDF]
Tak KY, Kim SH, Song MJ.
europepmc +1 more source

